Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2014 2
2015 2
2016 6
2017 7
2018 9
2019 5
2020 11
2021 7
2022 13
2023 7
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Frontiers in Chemistry: rising stars 2022.
Brites CDS, Contini D, He XP, Liu T, Moosa B, Pannico M, Rashed MN, Qiu Y, Zwergel C. Brites CDS, et al. Among authors: zwergel c. Front Chem. 2023 Nov 20;11:1334117. doi: 10.3389/fchem.2023.1334117. eCollection 2023. Front Chem. 2023. PMID: 38053672 Free PMC article. No abstract available.
Selenium-Containing Agents Acting on Cancer-A New Hope?
Garbo S, Di Giacomo S, Łażewska D, Honkisz-Orzechowska E, Di Sotto A, Fioravanti R, Zwergel C, Battistelli C. Garbo S, et al. Among authors: zwergel c. Pharmaceutics. 2022 Dec 28;15(1):104. doi: 10.3390/pharmaceutics15010104. Pharmaceutics. 2022. PMID: 36678733 Free PMC article. Review.
Trends of LSD1 inhibitors in viral infections.
Zwergel C, Stazi G, Mai A, Valente S. Zwergel C, et al. Future Med Chem. 2018 May 1;10(10):1133-1136. doi: 10.4155/fmc-2018-0065. Epub 2018 May 22. Future Med Chem. 2018. PMID: 29787289 Free article. No abstract available.
EZH2 inhibitors: a patent review (2014-2016).
Stazi G, Zwergel C, Mai A, Valente S. Stazi G, et al. Among authors: zwergel c. Expert Opin Ther Pat. 2017 Jul;27(7):797-813. doi: 10.1080/13543776.2017.1316976. Epub 2017 Apr 20. Expert Opin Ther Pat. 2017. PMID: 28394193 Review.
Editorial: Multi-target directed ligands for the treatment of cancer.
Brindisi M, Kessler SM, Kumar V, Zwergel C. Brindisi M, et al. Among authors: zwergel c. Front Oncol. 2022 Aug 5;12:980141. doi: 10.3389/fonc.2022.980141. eCollection 2022. Front Oncol. 2022. PMID: 35992885 Free PMC article. No abstract available.
The emerging role of epigenetics in human autoimmune disorders.
Mazzone R, Zwergel C, Artico M, Taurone S, Ralli M, Greco A, Mai A. Mazzone R, et al. Among authors: zwergel c. Clin Epigenetics. 2019 Feb 26;11(1):34. doi: 10.1186/s13148-019-0632-2. Clin Epigenetics. 2019. PMID: 30808407 Free PMC article. Review.
LSD1 inhibitors: a patent review (2010-2015).
Stazi G, Zwergel C, Valente S, Mai A. Stazi G, et al. Among authors: zwergel c. Expert Opin Ther Pat. 2016 May;26(5):565-80. doi: 10.1517/13543776.2016.1165209. Epub 2016 Mar 28. Expert Opin Ther Pat. 2016. PMID: 27019002 Review.
HDAC1/2 control mesothelium/ovarian cancer adhesive interactions impacting on Talin-1-α5β1-integrin-mediated actin cytoskeleton and extracellular matrix protein remodeling.
Terri M, Sandoval P, Bontempi G, Montaldo C, Tomero-Sanz H, de Turris V, Trionfetti F, Pascual-Antón L, Clares-Pedrero I, Battistelli C, Valente S, Zwergel C, Mai A, Rosanò L, Del Pozo MÁ, Sánchez-Álvarez M, Cabañas C, Tripodi M, López-Cabrera M, Strippoli R. Terri M, et al. Among authors: zwergel c. J Exp Clin Cancer Res. 2024 Jan 23;43(1):27. doi: 10.1186/s13046-023-02930-8. J Exp Clin Cancer Res. 2024. PMID: 38254102 Free PMC article.
67 results